News and Events
- October 23, 2014
TCGA study improves understanding of genetic drivers of thyroid cancer
A comprehensive analysis of the genomes of nearly 500 papillary thyroid carcinomas has provided new insights into the roles of frequently mutated cancer genes and other genomic alterations that drive disease development.
- August 21, 2014
Rare kidney tumor provides insights on role of metabolic changes in cancer
Researchers in the TCGA Research Network have made a number of new findings about the biology and development of a rare form of kidney cancer.
- August 12, 2014
Update: The Benefits of Looking Across Many Cancer Genomes
TCGA's Pan-Cancer project publishes its integrative analysis of TCGA cancer types. The Pan-cancer project's goal is to assemble TCGA’s wealth of data across tumor types, analyze and interpret those data, and finally, make both the analyses and the data freely available.
- October 06, 2014
Cancer Genome Sequencing Will Mean More Targeted Therapies
Forbes interviews Dr. Carolyn Hutter, NHGRI team lead for TCGA, about the influence of cancer genomics on the future of precision medicine.
- August 08, 2014
It’s Time for Us to Think About Cancer Differently
Newsweek reports on the most recent publication from TCGA's Pan-Cancer project in which researchers analyze 12 cancer types and reveal molecular classifications within and across tissues of origin.
- July 25, 2014
Study Finds Mutations in Lung Cancer DNA
The Boston Globe reports on The Cancer Genome Atlas Research Network's identification of the top 18 gene mutations associated with lung adenocarcinoma.
Histopathological image of cerebral glioblastoma.
View All Images >
The difference between a normal cell and cancer cell and how understanding the changes in DNA that cause cancer can help doctors develop better treatments.
View All Videos >
| From the NIH
View All Audio >